HIV & AIDS

New high-cost HIV prevention drug: 'Better' isn't worth it

A newly approved drug for HIV pre-exposure prophylaxis (PrEP) is unlikely to confer any discernible health benefit over generic alternatives and may undermine efforts to expand access to HIV prevention for the nation's most ...

Diabetes

Treating oral disease could yield T2DM-related cost savings

(HealthDay)—Providing nonsurgical periodontal treatment to patients with type 2 diabetes (T2D) and periodontitis may significantly reduce tooth loss and diabetes-related microvascular diseases via improved glycemic control, ...

Dentistry

Behavioral sciences in the promotion of oral health

2019 marks the Centennial of the Journal of Dental Research (JDR). Over the last century the JDR has been dedicated to the dissemination of new knowledge and information on all sciences relevant to dentistry and to the oral ...

Medications

Think you're allergic to penicillin? You are probably wrong

More than 30 million people in the United States wrongly believe they are allergic to penicillin—resulting in millions of dollars in added health care costs, adverse side effects from the use of more powerful antibiotics ...

page 1 from 9